phase one really could have gone much better for the oxford team early positive signs now confirmed in the published research this is an important milestone on the par but we're now moving rapidly forwards to trying to evaluate whether the vaccine actually protects the population . by conducting large scale trials we have 10000 people already vaccinated around the world we still see how the vaccine in older people more disease than the. that is so that's the subject of work and the be more public. the oxford vaccine is adapted from a common cold virus found in chimpanzees spike glycoprotein a genetic material from the code with 1000 virus was added the hope is the human body will develop immunity to the spike protein stopping the virus from entering cells and preventing infection tests indicate the vaccine produces 2 reactions by producing a defensive antibody response as well as t. cells which attack the infected cells t. cell response peaked just 14 days after volunteers were injected antibody response peak to 28 days and side effects were minor mainly just tiredness and headaches tr

phase one really couldn't have gone much better for the oxford team early positive signs now confirmed in the published research so this is an important milestone on the par but we're now moving rapidly forwards to trying to evaluate whether the vaccine actually protects the population. by conducting large scale trials we have 10000 people already vaccinated around the world we still need to see how the vaccine in older people more is the disease than the. that is so that's the subject of work and to be more public and. the oxford vaccine is adapted from a common cold virus found in chimpanzees spike glycoprotein a genetic material from the co with 19 virus was added the hope is the human body will develop immunity to the spike protein stopping the virus from entering cells and preventing infection tests indicate the vaccine produces 2 reactions by producing a defensive antibody response as well as t. cells which attack the infected cells t. cell response peaked just 14 days after volunteers were injected antibody response peak to 28 days and side effects were minor mainly just tiredne

the oxford team says it is a really important milestone.pleased with the results that are published today in the lancet, because we're seeing both neutralising antibody responses and t—cell responses that we are optimistic may be associated with protection. but we still need to conduct those trials to prove that that's the case in humans. but we don't know if the vaccine will work in the real world, and protect people from infection. trials have begun in south africa and brazil, both virus hotspots. so the answer there may come sooner than in the uk. so this is very good and is very promising to start with. however, we have seen vaccines reaching this point and also failing, so we need to be a little bit careful, and not quite popping the prosecco just yet. i can fit you both in at 12:45pm. perfect. these over—70s in southampton are all signing up to receive the vaccine. older people are more vulnerable to covid—i9. and our immune system weakens as we age, so whether the vaccine protects them is another key question that needs answering. ho

they really want other vaccines, the oxford team really wa nt vaccines, the oxford team really want thecines are going to fail. so good early immune responses are encouraging. but many will fall by the wayside. and we don't know which ones they will be and it's interesting why the government this morning said it had bought, got agreements to buy two other vaccines, one, a german — us and another french one, that take very different approaches to oxford's. we have a foot in several camps here with different types of coronavirus vaccine. that was our medical correspondent fergus walsh. the government has also signed deals to secure 90 million doses of two coronavirus vaccines being developed overseas — one of them in france, the other in the united states and germany. let's get more on the race for a vaccine from the head of global policy and advocacy at the wellcome trust, alex harris. alex, good afternoon to you. good afternoon, simon. what a frenetic time this is, and for the world of science, very exciting when you get news as we have just had from oxford. absolutely. i welcome these

positive aspects to start with 1st of all the vaccine that is being produced by the university of oxford and the general attitude it says is safe and induces in an immune reaction strong antibody and t. cell immune response up to day $56.00 of the ongoing trial that's important because the period covered in this lancet report only covers the 1st $56.00 days this is an ongoing trial but this is just looking at the 1st $56.00 days it was 1077 adults aged between 18 and 55 spread across 5 hospitals between the 21st of april in the 21st of may say this paper covers those 1st 56 days there was a subgroup study of 10 participants which suggests the responses of those antibody and t. cells may be even stronger after a 2nd dose of this prospective vaccine some on a side effects which appear to be restricted to things like headaches and some tiredness so that's positive as well that said it's very early 56 days not really enough to have a long term view of its of its safety and the report says further safety test sorry for the testing needed to see whether these lab results can be confirmed as ef

professor sarah gilbert heads up the team at oxford.ilbert heads up the team at oxford. >> that the antibody response and t-cell responses and those are two parts of the imm >> there's the antibody response tect agacell response and those are two parts of the immune system that ideally work together to protect against viral infections. >> reporter: antibodies and t- cells are the special forces of the immune system. antibodies detect a virus and neutralize it. t-cells help make antibodies but also act as assassins, attacking infected human cells, even retaining a memory of the virus, ready to mount a defense the next time they encounter the same pathogen. this seems like a big deal. >> no question about it. you see the real data, your shoulders come down and we are all getting a sigh of relief that we're getting immune responses that we as scientists hoped for. >> reporter: the c.e.o. of drug giant astrazeneca said today they're on track to start rolling out millions of doses by the fall. one glimpse of hope that people can get back to

the oxford team says it's a really important milestone.pleased with the results that are published today in the lancet, because we're seeing both neutralising antibody responses and t—cell responses that we are optimistic may be associated with protection, but we still need to conduct those trials to prove that that's the case in humans. but we don't know if the vaccine will work in the real world and protect people from infection. trials have begun in south africa and brazil, both virus hotspots. so the answer there may come sooner than in the uk. so this is very good and it's very promising to start with. however, we have seen vaccines reaching this point and also failing, so we need to be a little bit careful and not quite popping the prosecco just yet. i can fit you both in at quarter to one. perfect. these over—70s in southampton are all signing up to receive the vaccine. older people are more vulnerable to covid—i9. and our immune system weakens as we age, so whether the vaccine protects them is another key question that needs answer

could the oxford vaccine help end the coronavirus pandemic?

phase one really couldn't have gone much better for the oxford team early positive signs now confirmed in the published research this is a boat on the park but we're now moving rapidly forwards to try to evaluate whether the vaccine actually protects the population. by conducting large scale trials we have 10000 people already vaccinated around the world we still see how the vaccine in older people more is the disease than the. so that's the subject of work and to be more public and. the oxford vaccine is adapted from a common cold virus found in chimpanzees spike glycoprotein a genetic material from the co with 19 virus was added the hope is the human body will develop immunity to the spike protein stopping the virus from entering cells and preventing infection tests indicate the vaccine produces 2 reactions by producing a defensive antibody response as well as t. cells which attack the infected cells t. cell response peaked just 14 days after volunteers were injected antibody response peak to 28 days and side effects were minor mainly just tiredness and headaches treated with paracet

yes high expectation here from the oxford trial it's been produced by the oxford vaccine group astra zeneca will be the manufacturer and the general institutes have been at the forefront as well of this of this research now we know that they're already in phase 3 trial trials that's large scale testing of the prospective vaccine what we're waiting for today is the academic publication in the medical journal the lancet or their phase one results that's back from april when they tested the vaccine around 500 subjects early indications are pretty double effect producing a reaction both of antibodies and of t. cells antibodies important because how they work they attach themselves to the virus in essentially prevent the virus from infecting anything else t. cells work rather differently that kind of a certain type of t. cell is a kind of killer cell and it goes after the virus and actually. basically destroys it so for a vaccine such as what seems to be developing here in oxford to have both of those responses is very optimistic indeed and what we need to find out from the lancet when it

absolutely, minus side effect from the oxford one. -- minor.ddle in scottish foes. finally after a lot of foot dragging, this intelligence report is going to come out. the telegraph says it shows an attempt to meddle in the scottish vote. we do not get a huge amount of detail, but we are told it is a 50 page report, sounds a little thing to be for the amount of time, but last week we heard from dominic raab saying there had been russian actors involved in trying to meddle with the general election. it seems to have gone back a years previous according to this report and it was with the scottish independence referendum, so there will be a huge amount of pressure on borisjohnson to cool things down with mr putin, i've come up with some sort of punishment or some sort of retaliation. it will also put pressure on nicola sturgeon in the sense that she still has the main thing that she wants, another referendum, and since it is the russians advance, they are the ones pushing for this split and they would like it to happen because it could cause also

appears to be safe for humans for printing reports from oxford. phase one really could have gone much better for the oxford team early positive science now confirmed in the published research this is a boat on the par but we're now moving rapidly forwards to try to evaluate whether the vaccine actually protects the population. by conducting large scale trials we have 10000 people already vaccinated around the world we still see how the vaccine in older people more disease than the. that is so that's the subject of work and to be more public and. the oxford vaccine is adapted from a common cold virus found in chimpanzees spike glycoprotein a genetic material from the co with 19 virus was added the hope is the human body will develop immunity to the spike protein stopping the virus from entering cells and preventing infection tests indicate the vaccine produces 2 reactions by producing a defensive antibody response as well as t. cells which attack the infected cells t. cell response peaked just 14 days after volunteers were injected antibody respons

could the oxford vaccine help end the coronavirus pandemic?ore than 9,000 volunteers have received the jab in the uk — among them these frontline nhs staff in newcastle. i've seen what covid can do. the sort of severity of some of the cases has been quite upsetting at times, so i really wanted to try and help get rid of this disease. unfortunately, me dad fell ill with covid, and was admitted here for eight days. and i think, once it's been that close to home, it makes more of a difference. you feel like you want to do your bit. vaccines work by training the immune system to recognise and remember the enemy — in this case coronavirus. the oxford vaccine stimulates the creation of specialist y—shaped proteins known as neutralising antibodies. in the event of future exposure, these should latch onto the coronavirus and prevent infection. it also stimulates the creation of t—cells, another key part of the immune system. these should sweep up after the antibodies and destroy any cells that have become infected. in the first 1,000 volunteers, the v

the new report of the oxford vaccine. one of 23 now in human trials. what early results are now showing. researchers say so far, it is safe and effective. what the world health organization is saying tonight. and if all goes well from here, how soon before americans would have access to it? >>> meantime, coe strid 19 rising in 40 states. the line for testing stretching for miles in miami-dade county. >> if you had been infected -- >> and what happened today. florida's governor shouted down, blasted for his response early on. also, nearly 100 people receiving false positive tests. and on opening schools in this country, the governor tonight who is opening schools and he's under fire after saying when children are infected, they're going to go home and they're going to get over it. >>> after months of criticism, president trump late today tweeting this image of himself wearing a mask. and the president reviving his white house briefings, beginning tomorrow. amid poll numbers showing joe biden with a significant lead and americans questioning the presiden

>>> tonight, new hope in the race for a vaccine, scientists say oxford's vaccine candidate has been shown to be safe and produce a strong immune response. in an early trial, the double defense it may offer and how soon you might be able to get it it comes as more records are shattered, los angeles on the brink of another stay at home order. in miami beach an 8:00 p.m. curfew. florida again reporting over 10,000 daily cases, over 50 hospitals in the state out of icu beds. >>> president trump, after resisting wearing a mask, his new message to americans tonight and why he's bringing back his task force briefings. >>> plus, the growing list of retailers requiring masks. and delta's brand new policy the shocking ambush, a gunman disguised as a de federal judge, her husband critically wounded, tus york governor andrew cuomo from the one-time epicenter to the hot spot of georgia, his new mission. >>> federal agents violently clashing with protesters in portland, the wall of moms trying to keep the peace. >>> and the moment of silence today to honor a civil rights icon.is is "nbc nightly news" w

phase one really couldn't have gone much better for the oxford team early positive signs now confirmed in the published research so this is an important milestone on the par but we're now moving rapidly forwards to try to evaluate whether the vaccine actually protects the population. by conducting large scale trials we have 10000 people already vaccinated around the world we still need to see how the vaccine in older people more is the disease than the. that is so that's the subject of work and to be more public and. the oxford vaccine is adapted from a common cold virus found in chimpanzees spike glycoprotein a genetic material from the code with 1000 virus was added the hope is the human body will develop immunity to the spike protein stopping the virus from entering cells and preventing infection tests indicate the vaccine produces 2 reactions by producing a defensive antibody response as well as t. cells which attack the infected cells t. cell response peaked just 14 days after volunteers were injected antibody response peak to 28 days and side effects were minor mainly just tiredn

thank you then paul brennan live for us in oxford. or heard about the efforts to combat covert 19 but what's it like to actually have the virus to cross and who is an old friend she is a recovering coronavirus patient was actually one of the very 1st cases in new zealand thanks for the program to me what was your experience of having coronavirus like. thanks for having me michel to the point of i've actually got a suturing this wait for him to make sure it's this which i haven't had a player in a long time. having had a hysterectomy last year i didn't expect if i had one again and there are some research around inflammation in the body in the connection from covert courses early days and no one really knows i guess that's the thing isn't it we're still learning about the virus and about how people who've had the virus are moving on and the on going impacts on their body or you know hyper vigilant at all sort of keeping an eye out for oh that's different or you know sort of just noticing more things in your body well he said yes i know

good evening, charlie. >> norah, reason to be hopeful here in oxford tonight. one of the largest human trials in the world has proven two things, it's safe and at this stage it works it is important to know here it does not guarantee protection for everybody. that will take more research but the woman in charge of that research told us tonight she believes immunity should last for more than a year. it's rock solid evidence that proves why the world health organization calls the oxford vaccine the world's most advanced candidate. a peer reviewed study in today's lance et medical journal found that trials on more than a thousand people triggered a strong immune response, provided protection for at least two months. caused zero side effects apart from fatigue and headaches. professor sarah gilbert heads up the team at oxford. >> that the antibody response and t-cell responses and those are two parts of the immune system that ideally work together to protect against infections. >> antibodies and t-cells are the special forces of the immune system. antibodies detect

the oxford team say it's a really important milestone.ith the results that are published today in the lancet, because we're seeing both neutralising antibody responses and t—cell responses that we are optimistic may be associated with protection, but we still need to conduct those trials to prove that that's the case in humans. but we don't know if the vaccine will work in the real world and protect people from infection. trials have begun in south africa and brazil, both virus hotspots. so the answer there may come sooner than in the uk. so this is very good and it's very promising to start with. however, we have seen vaccines reaching this point and also failing, so we need to be a little bit careful and not quite popping the prosecco just yet. i can fit you both in at quarter to one. perfect. these over—70s in southampton are all signing up to receive the vaccine. older people are more vulnerable to covid—i9. and our immune system weakens as we age, so whether the vaccine protects them is another key question that needs answering. how

found their vaccine did not cause any serious side effects or produced a strong immune response from oxford here is paul brennan. it is early on about the 1st $56.00 days all of the phase one trial that took place end of april beginning of may involving $1077.00 participants that said the results of that early testing and early study was that it is safe this vaccine this potential vaccine that they produced it induces an immune reaction which is good it in 3 uses 2 types of immune reaction that is antibodies and t. cells the reaction is strong and in a subgroup study of 10 participants which is yes that the response is maybe even stronger after a 2nd dose now the ideal vaccine needs to be effective after just wanted to do says it needs to be good for. the elderly people and target participants such as people with existing health conditions it also needs to be effective for a period of longer than 6 months and at this stage it's too early to say whether or not this vaccine actually meets those kind of criteria what hasn't happened here is the pitot participants have not been exposed to coron

excluding oxford then just on that point, if we take out oxford, then we ought to be preparing to face be a reasonable assumption, yes. 0k. sarah gilbert is leading the oxford trials. i hope we can improve on those timelines and come to your rescue. obviously, the thing that we have to do is show that the vaccine works. so, these things are very unpredictable and that's why i can't give you a firm timeline. i can just tell you that we are vaccinating in multiple countries where there is high transmission. so, we are increasing the chances of getting the efficacy result early. professor sirjohn bell said medical professionals were worried about how to manage seasonal flu on top of covid—19. because you will get people with severe pneumonia, arriving with fevers, and all the usual things and it will be pandemonium in the a&e departments. so, what i'm rather hoping is that we first of all, ideally expand the number of people getting flu vaccines so we get better coverage. and secondly, we push quite hard to make sure people are compliant in participating in the flu vaccine programmes. the

we begin our coverage from oxford. reporter: phase one could have gone better for the oxford team.arly positive signs now confirmed in the research. >> this is an important milestone on the path and we are moving rapidly forward to try and evaluate whether the vaccine actually protects the population by conducting large-scale trials. we have 10,000 people around the world. >> we still need to see how the vaccine performs in older people who are more susceptible to disease. there will be more complications to compute reporter: -- convocations to come. reporter: the vaccine is developed from a disease and champion -- chimpanzees. human body that the will develop immunity to the spike protein and prevent infection. the vaccine produces two reactions, producing a defensive antibody response as well as t cells that attack the infected cells. t cell response takes just 14 days after volunteers were injected. antibody response peaked at 28 days, and side effects were monarch, mainly -- were minor, mainly tiredness and headaches. >> i have my fingers crossed them up but to say that we will

today thanks for that paul brennan live for us in oxford. deadlock and division is gripping the european union has its leaders struggle to compromise on a major coronavirus economic rescue deal leaders will meet for a 4th time after sunday's talks stretched into the night without an agreement has more it's how to share $857000000000.00 the questions confounded e.u. leaders for days and deepened divisions within the block in one camp nations known as the frugal for austria denmark sweden and the netherlands the wealthy northern states pay the most per capita into the e.u. shared reserves they want strict controls on how the recovery fund is shared prefer ing to loan countries money the positions at odds with spain and italy both economies were hit hard by the pandemic they want generous grants from the bloc that don't need to be repaid the german chancellor angela merkel and french president emmanuel mccrone have been trying to broker a compromise by offering e.u. countries a combination of loans and grants but the latest can't agree on how t

oxford has historically also not been promotional why? university they don't trade but i do think that what we're after is kind of a handicap. we're trying to figure out which one pfizer is doing very well. regeneron quiet and j&j remarkable you're not going to get alex saying we're in the lead and you're also not going to get a moderna situation where everything is really good and that's why they end up selling a ton of stock i'm sorry to be so brutal about mode moderna. they should have called the sec and said we're cancel. they didn't do that and it's so ill advised that it is a travesty >> really. so, you think even with all the explanations and all the justifications for the sales of the cmo and the ceo, you think it just lends itself to guilt by association? >> i've been in these situations before personally and i know exactly what you have to do. no transactions. no buying, no selling. any good attorney who's working with moderna has shopped or i think would be a shyster you don't just simply do what they're doing. there's so much

vaccine as well as from the oxford vaccine as well as from the oxford vaccine as well as from the pfizerincluding in clinical trials. what we have done today is to create a page on the nhs website which allows people to sign up to register their interest in joining clinical trials and really make a difference in the fight back against covid. the website is nhs start forwards coronavirus. it does not permit you tojoin forwards coronavirus. it does not permit you to join the clinical trial, it just indicates permit you to join the clinical trial, itjust indicates your interest to learn more. when we speak to doctors on this programme, they often say there is so much attention in the nhs and treating coronavirus, that other services have been either slowed down or things will take more time to get through. is it the same with the vaccine business? are there other things you would ordinarily have been working on that you have had to put to one side because you have been focusing on covid—19? put to one side because you have been focusing on covid-19? all clinical trials during the immediate

live to paul brennan at oxford university in the u.k. so paul we're still waiting on the uploading of this information to the lancet website what can we expect do we think. well as you heard sarah say there the optimism the cheese been expressing in recent weeks is leading to high expectation here in oxford and in the wider field because the early indications appear to be that the oxford university trials have shown that it's vaccine candidates produces both antibody and t. cell response from the body now antibodies of course lock on to the virus and neutralize it off like it up for other parts of the immune system to attack it is a slightly different to one particular cell actually attacks the virus so if it produces reactions from both of those kind of things then then it basically makes it very optimistic indeed that said we're waiting for the lancet to actually publish the data so this is data relating to phase one volunteer about 500 volunteers engaged in the process we know that there haven't been any major side effects because the

we have the oxford programme where we have secured 100 million doses.i'm 100% confident we will get a vaccine this year or indeed next year, is alasjust, this year or indeed next year, is alas just, you know, this year or indeed next year, is alasjust, you know, an exaggeration. we are not there yet f you talk to the scientists, they think the sheer weight of international effort will produce something. they're pretty confident we will get some sort of treatment, some sort of vaccines that really make a difference. can i be right now, it will you i'm100% confident? no. that is why we have got to continue with our current approach, maintaining social distancing measures, as you have seen in this school, where they're doing an amazing job, we have to do the sensible things, washing our hands, wearing face masks in confined spaces, all those things and then we will continue to drive the virus down by our own collective action. it may be that the vaccine is going to come riding over the hill like the cavalry, but we can't count on it now. the prime minister

there's the university of oxford astra zeneca which is testing its vaccine in big numbers of people in the u.k. south africa and brazil it's expected to release the results of its 1st human clinical trial shortly in australia the university of melbourne and murdoch children's research institute is also conducting phase 3 trials and chinese companies sin of rock and sin a farm well they've both moved to phase 3 testing in brazil and also in the u.a.e. sara gilbert is a research leading the trials the university of oxford speaking virtually to members of the house of commons the british parliament in london she said her team is still testing for how long the vaccine will provide immunity to the virus nationally quite immunity to other human actions it is relatively short that we don't get reinfected sometimes quite quickly but that doesn't necessarily mean it will see the same thing with the vaccine because the vaccines have a different way of engaging with the need system and we follow people enough that since it is using the same type technology to make vaccines several years and we st

the telegraph says oxford scientists believe they've made a breakthrough in their search for a covid—ne, after discovering that the jab triggers a response that may offer a "double defence" against the virus. the times also leads with that story and says volunteers in the trial are understood to have shown encouraging levels of neutralising antibodies, thought to be important in protecting against viral infection, and there were no serious side—effects. the express is jubilant, saying the success at trial raises hope that there will be a vaccine by the end of 2020. the metro goes with what it calls growing confusion over the need to wear masks in shops in england, with health secretary matt hancock and no.10 appearing to give conflicting advice. the daily mail says speed cameras are being used to make money rather than prevent deaths, according to an official report. the police watchdog says some locations are chosen because they are "‘good hunting grounds‘ for fines. and the guardian says the uk labour party is poised to make a formal apology to anti—semitism whistle—blowers as part

as the results of t oxford coronavirus vaccine trial are encouraging and led to a strong immune responsein the u.s., millions of americans risk losing o emoyment benefits unless congress can come to a deal on pandemic spending. tensions rise between london and beijing as the u.k. suspends its kong. treaty with hong ♪ laura: for all of you watching, welcome to world news america. there is hope in the fight agnst coronavirus as scientists at oxford say they have reached an important milestone in their work on vaccine. developing appears to be safe and triggers an immune respod e ba trials. experts say it is too soon to kn how much protection the vaccine offers. our medical correspondent,rg fe walsh, has the story. feucrgus: sois riding on this. could the oelord vaccine h end the coronavirus pandemic? more than 9000 volunteers have received the jab in the u.k., among them these front nine nhs stf in newcastle. >> i have seen what covid can do. itthe sevof some cases has been quite upsetting at times. i want to try and help get rid of this disease. >> unfortunately my dad fell ill with covid

could the oxford vaccine help end the coronavirus pandemic?ore than 9000 volunteers have among them these fine nhs., staff in newcastle. >> i have seen what covid can do. the severity of some cases has been quite upsetting at times. i want to try andp h get rid of this disease. >> unfortunately my dad fell ill with covid and was admitted here for eight days. i think once it has been that close to home, you feel like you want to do your bit. fergus: vaccines work by the immune system to recognizein this case, coronavi. the oxfo vaccine stimulates the creation of specialized y -shaped proteins known as the event of future exposure, atthese should onto the coronavirus and prevent infection. it also stimulates the creation of t cells, another key part of the immune system. these should sweep up after the antibodies and destrat any cells th have become infected. in the first 1000 volunteers, the vaccine was safe and two doses gaveon an even sr immune responsehan one. the oxford team say it is a really important milestone. >> we are reallyleed with

but there is one concern, in both this oxford study, the trial, and in the moderna study, the people that volunteered were adults between the ages of 18 and 55, and the people who are at risk for severe disease and death are people over the age of 70 and people with underlying health problems. so what we really need to know, are these vaccines also equally effective, or, you know, protective for these vulnerable pop place that we don't know yet. >> yeah, that is a very good point. obviously, i'm going to guess that once the trial expands, perhaps they'll bring in some more of those who fall in that category you mentioned. when you talk about the vac seen being made by moderna, we saw similar results, including side effects. in both of these trials, there are side-effects, but they are deemed to be mild, moderate, and most people get over them relatively quickly. >> yeah. so in the oxford trial, they actually used tylenol in people who got the vaccine, and that reduced some of the side- effects. the most common side everything was fever and pain at the site of injection, things like t

the newspaper says that the oxford vaccine could train the body to fight off the virus.he i also leads on the vaccine progress, but it adds that further large—scale testing is still needed, before it can be rolled out. the guardian says that the prime minister has called the results from the oxford team "very positive" and "a step in the right direction". the times welcomes the fact that there were no serious side—effects in the vaccine trial, which involved over 1,000 volunteers. the telegraph goes with a different story. it says the long—awaited report into alleged russian interference in uk democracy will lay bare the kremlin‘s meddling in the scottish independence vote. that report is due to be published tomorrow morning. and front line workers battling coronavirus in the uk could be set to receive pay rises — that's according to the express. we will come to that in a moment. but let's start off with the guardian. hopes of coveted 19 vaccine raise as uk study hailed as break there. but several sites around the world. at the moment there are two vaccines that will rea